-
Sort By
-
Newest
-
Newest
-
Oldest
It’s been a while since “value investing” made sense: the style has suffered a dreadful stretch of performance since the 2008 financial crisis. The ‘Warren Buffett’ mantra of buying low (cheap) and selling high has seen value-oriented managers underperform the market year after year. But that’s not to say value investing is dead, it’s just…
Hamish Douglass, the CIO of Magellan Financial Group, who oversees the largest Australian-owned global funds manager and is the current darling of both the wholesale and retail investor sectors, is relatively sanguine about the possible market impact of the US election, but a bit more worried about COVID-19. Douglass, also Magellan’s co-founder, with Chris Mackay,…
Building a financial advisery practice isn’t easy. From regulation to compliance, overheads to staff wages and client reporting to administration, there are so many time-consuming, ad hoc tasks that take up the time of an adviser which could be better spent dealing with clients. The solution? Streamline and automate manual, time consuming processes. And this…
Here’s the fourth instalment of our series on the fascinating ASX cohort of medical device developers. ImpediMed (IPD, 8.1 cents)Market capitalisation: $83.8 millionThree-year total return: -52.7% a yearAnalysts’ consensus target price: 14 cents (Thomson Reuters) You would not know it from the share price performance over the last few years, but Brisbane-based ImpediMed has put…
One of the great investment success stories of the last 25 years has been the exchange-traded fund (ETF), which got under way in the early 1990s as a vehicle offering access in one listed stock, to the entire stock market through tracking an index. Gone were the worries of paying “active” management fees and failing…